PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30445019-0	2019	Resveratrol protects cardiomyocytes against anoxia/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 beta pathway.	Resveratrol	0-11	AKT serine/threonine kinase 1	Homo sapiens	99-102	
30445019-10	2019	In addition, Akt and its downstream glycogen synthase kinase 3 beta (GSK3beta) were phosphorylated by the action of resveratrol.	Resveratrol	116-127	AKT serine/threonine kinase 1	Homo sapiens	13-16	
30445019-11	2019	Akt inhibitor IV abrogated Akt-GSK3beta phosphorylation and thereby abolished the dephosphorylation activity of resveratrol on VDAC1.	Resveratrol	112-123	AKT serine/threonine kinase 1	Homo sapiens	0-3	
30445019-11	2019	Akt inhibitor IV abrogated Akt-GSK3beta phosphorylation and thereby abolished the dephosphorylation activity of resveratrol on VDAC1.	Resveratrol	112-123	AKT serine/threonine kinase 1	Homo sapiens	27-30	
30445019-12	2019	Moreover, all resveratrol-mediated protective effects on A/R injured cardiomyocytes were abolished by Akt inhibitor IV.	Resveratrol	14-25	AKT serine/threonine kinase 1	Homo sapiens	102-105	
30445019-13	2019	Taken together, our data indicated that A/R injury enhanced VDAC1 phosphorylation in cardiomyocytes, whereas pretreatment with resveratrol dephosphorylated VDAC1 through the Akt-GSK3beta pathway, thereby protecting cardiomyocytes against A/R injury.	Resveratrol	127-138	AKT serine/threonine kinase 1	Homo sapiens	174-177